VIP treatment decreased the number of apoptotic cells and increased cell proliferation. VIP treatment decreased the number of apoptotic cells and increased.

Slides:

Advertisements

Similar presentations

Figure 1 Body weight of control and BPA-treated mothers after delivery

Advertisements

by Christina K. Ullrich, Jerome E. Groopman, and Ramesh K. Ganju

GM-CSF induces tumor cell EMT and stemness.

by Simon F. De Meyer, Alexander S. Savchenko, Michael S

Nat. Rev. Clin. Oncol. doi: /nrclinonc

IL-6 is dispensable for the suppressive activity of MDSC on primary CD4+ T-cell activation. IL-6 is dispensable for the suppressive activity of MDSC on.

Hui-Fang Song et al. BTS 2017;2:

BrdU/Albumin/Hoechst

Fig. 5. Nutlin-3 treatment rescues the proliferation and differentiation of NPCs in vitro. Nutlin-3 treatment rescues the proliferation and differentiation.

Figure 1 Evolution of blood cell counts during 18-month treatment and follow-up (A) Mean white blood cell count, (B) mean lymphocyte count, (C) mean eosinophil.

Overexpression of HGF decreases MET protein levels.

TDP1 knockdown increases the sensitivity of rhabdomyosarcoma cell lines to CPT treatment. TDP1 knockdown increases the sensitivity of rhabdomyosarcoma.

Defective yolk sac vascularization in RapGEF2−/− mice.

MP cells consist of rapidly proliferating CD5hi and relatively quiescent CD5lo cells, both of which require CD28 signaling for Ki67 expression. MP cells.

Mammary cell proliferation is inhibited when LAD1 is depleted.

Fig. 3. Knockdown of cited3 results in increased cell death but it does not affect proliferation.Embryos that are injected with the control MO (A–C), cited3.

Islet mass and β-cell proliferation is decreased in Hhip–/– embryos (Hip1 in figure). Islet mass and β-cell proliferation is decreased in Hhip–/– embryos.

Α-Catenin DKO cardiomyocytes exhibit increase proliferation on stiff ECM. (A) Representative images of neonatal cardiomyocytes cultured on different PA-FN.

Fig. 5. Combination of SAHA and ML produces augmented suppression of cellular proliferation with impaired cell cycle progression, enhanced apoptotic.

Effect of insulin on hepcidin expression in HepG2 cells.

Sources of new β-cells. 1. Sources of new β-cells. 1. Proliferation of β-cells, which requires specific cyclins, cyclin-dependent kinases (cdk), and the.

Pancreatic β-cell proliferation.

PD-1, but not PD-L1, expressed by the BDC2

Cell proliferations, ROS production, and ATP levels in HASMCs cultured under high-glucose condition. Cell proliferations, ROS production, and ATP levels.

Effect of M-cadherin RNAi and GSK-3β inhibition on myogenic differentiation of C2C12 myoblasts. Effect of M-cadherin RNAi and GSK-3β inhibition on myogenic.

Immune cell activation detected by gene expression in representative pancreatic islets of IDDM rats after successful combination therapy with anti–TNF-α.

Grg3 is expressed in most β-cells but less frequently in α-cells.

Metformin and rapamycin decreased tumor weights in obese prediabetic mice. Metformin and rapamycin decreased tumor weights in obese prediabetic mice. A:

E11 pancreas cultured for 6 days in the presence of morpholine-ring antisense against GIP, GIPR, or control. E11 pancreas cultured for 6 days in the presence.

Npas4 induction is cytoprotective for pancreatic β-cells.

GLP-1 and gastrin combination therapy increases pancreatic insulin content (A) and β-cell mass (B) in NOD mice. GLP-1 and gastrin combination therapy increases.

Decreased KATP activity for SUR1 (ABCC8) channels harboring R1420H or R1420C mutations. Decreased KATP activity for SUR1 (ABCC8) channels harboring R1420H.

Expression of VPAC2 in the pancreas at E13.

Reversal of diabetes-induced depletion of bone marrow (BM)–resident LSK cells and impairment of proliferation by ANG-(1-7) treatment. Reversal of diabetes-induced.

Glucose-stimulated insulin secretion, plasma glucagon levels, and pancreatic hormone contents. Glucose-stimulated insulin secretion, plasma glucagon levels,

Homing and proliferation of antigen-specific T-cell (A) CFSE staining of polyclonal (CD4), GAD p286–specific (GAD), and BDC2.5 cells in pancreatic lymph.

Comparison of the percentages of ducts in the pancreas containing cells showing positive staining for the different markers between control hamster Ig–and.

Expression of PKCδ in islets and other tissues of control and PKCδKN-overexpressing mice. Expression of PKCδ in islets and other tissues of control and.

SiRNA directed at Ngn1 inhibited differentiation of inner ear stem cells to β-III tubulin-positive cells. a, Inner ear stem cells treated with siRNA to.

Aplf downregulation does not induce cellular arrest.

A: Photomicrograph of a fibrin gel containing ∼50 islets 2 h after polymerization of a 5-μl fibrinogen solution containing the islets with 5 μl thrombin.

Morphologic changes induced in immortalized human podocytes after treatment with TGF-β1 (10 ng/mL, right) for 3 days when compared with control cells (left),

Comparison of the percentages of ducts in the pancreas containing cells showing positive staining for the different markers between control patients and.

Increased pancreatic insulin content and islet size and protection against HFD- and palmitate-induced cell death in PKCδKN-overexpressing mice. Increased.

Apoptosis in CAM vessels after staining with TUNEL

Chronic rapamycin treatment impairs β-cell mass and insulin clearance in rats. Chronic rapamycin treatment impairs β-cell mass and insulin clearance in.

Decreased M1 and increased M2 macrophages in eWAT and liver of DIO mice due to linagliptin administration. Decreased M1 and increased M2 macrophages in.

Persistence of hyperplastic islets lacking proliferating and apoptotic cells in some RIP7-rtTA × tet-Tag mice. Persistence of hyperplastic islets lacking.

NAPRT expression correlates to sensitivity for NAMPT inhibitors and to methylation of the CpG island of the NAPRT promoter. NAPRT expression correlates.

Mast cell and microglial proliferation in the developing POA

Identification of NSC as a FADD-kinase inhibitor.

PRIMA-1Met inhibits the growth of multiple myeloma tumors with mutant p53 in vivo. PRIMA-1Met inhibits the growth of multiple myeloma tumors with mutant.

Heat map of genes for which CR significantly altered expression versus AL. Cluster analysis of genes significantly changed by the CR intervention compared.

CNDT2.5 cells express mRNA for synaptophysin and neuron-specific enolase. CNDT2.5 cells express mRNA for synaptophysin and neuron-specific enolase. RT-PCR.

Tumors treated with anti-Flk-1 mAb have increased tumor cell apoptosis, reduced tumor cell proliferation, and increased tumor necrosis. s.c. Tumors treated.

Pancreatic cancer cell lines are sensitive to knockdown of outlier kinases. Pancreatic cancer cell lines are sensitive to knockdown of outlier kinases.

Increase in proliferation and activation of immune cells in peripheral blood after NKTR-214 treatment. Increase in proliferation and activation of immune.

Effect of bFGF on ultrastructure of RD-ES cells.

Effects of EGCG on the anchorage-independent growth of EFT cells.

Correlations of the breast cancer hypoxia metagene with Ki67 and the proliferation metagene. Correlations of the breast cancer hypoxia metagene with Ki67.

A, VEGFR2 staining in the tumor rim and center.

P53-expressing tumor cells circumvent mitosis, express markers consistent with a G1-like state, and become senescent in response to continuous chemotherapeutic.

Blockade of cell cycle at G2-M phase in Bel-7402 cells treated with IG-105. Blockade of cell cycle at G2-M phase in Bel-7402 cells treated with IG-105.

Effect of BCAA on the progression of cell cycle, expression of p21CIP1, and induction of apoptosis in HepG2 cells in the presence and absence of visfatin.

Autophagy mediates postslippage cell fate.

Curcumin decreases viability and proliferation of Bcr-Abl-expressing cells. Curcumin decreases viability and proliferation of Bcr-Abl-expressing cells.

Reduced β-catenin and cyclin D1 expression and increased apoptosis in lactating mammary gland epithelia of DDTg mice. Reduced β-catenin and cyclin D1 expression.

WEE1 inhibition followed by TRAIL treatment results in apoptotic cell death in MB231 cells. WEE1 inhibition followed by TRAIL treatment results in apoptotic.

Transcriptome profiling of PD-L1 antibody–treated macrophages showed inflammatory phenotype, increased survival and proliferation, and decreased apoptosis.

Western blot analysis of explanted human islets from control donors infected in vitro with CBV-1-11 revealed decreased expression of the CAR protein compared.

Presentation transcript:

VIP treatment decreased the number of apoptotic cells and increased cell proliferation. VIP treatment decreased the number of apoptotic cells and increased cell proliferation. Pancreatic epithelia were grown for 8 h with or without VIP and were pulsed with BrdU during the last hour. TUNEL-positive cells were revealed in green (A and B) and counted (E). BrdU-expressing cells were revealed in red (C and D) and counted (F). Three rudiments were analyzed for each condition. *P < 0.05. Latif Rachdi et al. Diabetes 2003;52:85-92 ©2003 by American Diabetes Association